Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

Hiroaki Iwata; Elena Pipi; Nicole Möckel; Peter Sondermann; Artem Vorobyev; Nina Van Beek; Detlef Zillikens; Ralf J. Ludwig

doi:10.1038/jid.2014.451

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

Hiroaki Iwata^*, Elena Pipi, Nicole Möckel, Peter Sondermann, Artem Vorobyev, Nina Van Beek, Detlef Zillikens, Ralf J. Ludwig

^*Corresponding author for this work

Clinic of Dermatology, Allergology and Venerology

SuppreMol GmbH

14 Citations (Scopus)

Original language	English
Journal	Journal of Investigative Dermatology
Volume	135
Issue number	3
Pages (from-to)	916-919
Number of pages	4
ISSN	0022-202X
DOIs	https://doi.org/10.1038/jid.2014.451
Publication status	Published - 01.01.2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/jid.2014.451

Cite this

@article{8e652e40f73146228aa570d94a02dced,

title = "Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita",

author = "Hiroaki Iwata and Elena Pipi and Nicole M{\"o}ckel and Peter Sondermann and Artem Vorobyev and {Van Beek}, Nina and Detlef Zillikens and Ludwig, {Ralf J.}",

year = "2015",

month = jan,

day = "1",

doi = "10.1038/jid.2014.451",

language = "English",

volume = "135",

pages = "916--919",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

number = "3",

}

TY - JOUR

T1 - Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

AU - Iwata, Hiroaki

AU - Pipi, Elena

AU - Möckel, Nicole

AU - Sondermann, Peter

AU - Vorobyev, Artem

AU - Van Beek, Nina

AU - Zillikens, Detlef

AU - Ludwig, Ralf J.

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84922621645&partnerID=8YFLogxK

U2 - 10.1038/jid.2014.451

DO - 10.1038/jid.2014.451

M3 - Letters

C2 - 25330298

AN - SCOPUS:84922621645

SN - 0022-202X

VL - 135

SP - 916

EP - 919

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 3

ER -

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

UN SDGs

Access to Document

Other files and links

Cite this